CD44 and breast cancer: In contrast, triple‐negative BCSCs in all IR doses significantly increased the expression of CD44+/CD24−/low surface markers, which has been related to radioresistance and poor prognosis in BC patients (Kim et al., 2016; Phillips et al., 2006; Wang et al., 2017).